ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is DHG Pharmaceutical JSC ?
1
High Management Efficiency with a high ROE of 20.35%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 57.01
3
Poor long term growth as Net Sales has grown by an annual rate of 5.44% over the last 5 years
4
Flat results in Sep 25
- INTEREST(Q) Highest at VND 9,939.5 MM
5
With ROE of 22.34%, it has a fair valuation with a 3.50 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 1.08%, its profits have risen by 2.8% ; the PEG ratio of the company is 5.6
- At the current price, the company has a high dividend yield of 9.9
6
Underperformed the market in the last 1 year
- The stock has generated a return of 1.08% in the last 1 year, much lower than market (Vietnam VN Ho Chi Minh Index) returns of 43.59%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to DHG Pharmaceutical JSC should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is DHG Pharmaceutical JSC for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
DHG Pharmaceutical JSC
-5.26%
-0.99
16.61%
Vietnam VN Ho Chi Minh Index
38.87%
1.90
22.90%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.00%
EBIT Growth (5y)
4.06%
EBIT to Interest (avg)
57.01
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.47
Sales to Capital Employed (avg)
0.98
Tax Ratio
13.16%
Dividend Payout Ratio
79.26%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
45.64%
ROE (avg)
20.35%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
3.23
EV to EBIT
11.50
EV to EBITDA
9.50
EV to Capital Employed
5.59
EV to Sales
2.15
PEG Ratio
1.03
Dividend Yield
5.81%
ROCE (Latest)
48.61%
ROE (Latest)
20.91%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -5.55% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -50.02 %
INVENTORY TURNOVER RATIO(HY)
Highest at 2.46 times
OPERATING PROFIT(Q)
Highest at VND 358,692.04 MM
OPERATING PROFIT MARGIN(Q)
Highest at 29.94 %
PRE-TAX PROFIT(Q)
Highest at VND 347,269.18 MM
NET PROFIT(Q)
Highest at VND 305,706.96 MM
EPS(Q)
Highest at VND 2,338.17
-1What is not working for the Company
CASH AND EQV(HY)
Lowest at VND 4,376,177.25 MM
Here's what is working for DHG Pharmaceutical JSC
Operating Profit
Highest at VND 358,692.04 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (VND MM)
Operating Profit Margin
Highest at 29.94 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at VND 347,269.18 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (VND MM)
Net Profit
Highest at VND 305,706.96 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (VND MM)
EPS
Highest at VND 2,338.17
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (VND)
Debt-Equity Ratio
Lowest at -50.02 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 2.46 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -5.55% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for DHG Pharmaceutical JSC
Cash and Eqv
Lowest at VND 4,376,177.25 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
